Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2525
-0.0195 (-7.17%)
At close: Aug 28, 2026, 4:00 PM EDT
0.2575
+0.0050 (1.98%)
After-hours: Aug 28, 2026, 7:52 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $40.32 million as of August 28, 2026. Its market cap has decreased by -85.60% in one year.
Market Cap
40.32M
Enterprise Value
11.23M
1-Year Change
-85.60%
Ranking
Category
Stock Price
$0.25
ChartMarket Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $40.32M, a decrease of -67.70%. That is a compound annual growth rate of -14.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 40.32M | -39.19% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Impact BioMedical | 47.55M |
| Werewolf Therapeutics | 47.18M |
| Veru Inc. | 46.72M |
| Metagenomi Therapeutics | 45.71M |
| Grace Therapeutics | 45.44M |
| Filana Therapeutics | 44.59M |
| Aligos Therapeutics | 44.15M |
| Karyopharm Therapeutics | 44.00M |